TREATMENT READING
Myeloproliferative Neoplasms
Choose a source section by treatment, subtype or setting. Patient and professional reading are labelled separately.
Selected text from the National Cancer Institute, with original links and dates. This Triangle reading page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
8 studies cited in this topic · see design and results →
Explore 1 related disease and treatment settings → · Source-derived catalogue; clinical review pending.
Certain factors affect prognosis (chance of recovery) and treatment options for essential thrombocythemia.
Certain factors affect prognosis (chance of recovery) and treatment options for primary myelofibrosis.
Treatment Option Overview
Key Points
There are different types of treatment for patients with myeloproliferative neoplasms.
The following types of treatment are used:
Watchful waiting
Phlebotomy
Platelet apheresis
Transfusion therapy
Chemotherapy
Radiation therapy
Other drug therapy
Surgery
Immunotherapy
Targeted therapy
High-dose chemotherapy with stem cell transplant
New types of treatment are being tested in clinical trials.
Treatment for myeloproliferative neoplasms may cause side effects.
Follow-up care may be needed.
Treatment of Chronic Myeloid Leukemia
Treatment of Polycythemia Vera
Treatment of Essential Thrombocythemia
Treatment of Primary Myelofibrosis
Treatment of Chronic Neutrophilic Leukemia
Treatment of Chronic Eosinophilic Leukemia
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle